If you are researching GLP-1 medications and their effects on energy levels, our article about whether Wegovy causes fatigue explores common questions about tiredness with similar medications
Works through metabolic enhancement, not hunger reduction
Understanding semaglutide How semaglutide aids weight loss Beyond weight loss Safety and side effects Semaglutide and weight management References Further reading Semaglutide, commonly known as Ozempic, is a glucagon-like peptide 1 (GLP-1) agonist utilized for glycemic control in type 2 diabetes (T2D) and obesity management
Novo's Wegovy Pill, by comparison, achieved 13.9% placebo-adjusted weight loss at 64 weeks
This is why weight loss is best understood as a downstream effect rather than the first measurable change
Also, during STEP 5, a study to assess efficacy of semaglutide with a follow-up of 2 years, there is a post-hoc analysis that demonstrates a better performance in the self-reported Control of Eating Questionnaire(CoEQ) to measure changes in appetite versus placebo, with lower cravings for dairy and starchy foods and less desire for salty and spicy food at short-term (20 weeks) but also as a maintenance therapy at weeks 52 and 104 (178)